Followers | 44 |
Posts | 13348 |
Boards Moderated | 0 |
Alias Born | 02/27/2005 |
Tuesday, June 26, 2018 3:02:42 PM
"During the quarter ended March 31, 2018, the Company received net proceeds from convertible debentures of $207,000 (2017: $628,060).
During the quarter ended March 31, 2018, $60,300 (2017: $240,484) of convertible debentures were settled by issuing 543,000,000 (2017: 435,823,830) shares of common stock of the Company".
https://backend.otcmarkets.com/otcapi/company/sec-filings/12688754/content/html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM